Orbit · 2019 · 34 citations · 9 references
MedicineDermatologyImmunologyImmunopharmacologyImmunotherapyInflammationAtopic DermatitisImmunopathology Of SkinImmunopathology Of The EyeInflammatory Skin DiseasesType I HypersensitivityAdverse Ocular EffectsAtopic Dermatitis ImmunopathologyAtopic Dermatitis PathogenesisAtopic Dermatitis PharmacotherapyAtopic Dermatitis TreatmentAtopic InflammationPeriocular Dermatitis ManagementSide Effect Profile
Dupilumab is a monoclonal antibody used to treat atopic dermatitis. Worsening of atopic dermatitis and conjunctivitis following dupilumab use are reported adverse effects; however, there is little reported on the nature and mechanism of these complications. Here, we describe two patients with chronic atopic dermatitis who developed new or severely worsened periocular dermatitis, believed to be a side effect of dupilumab injections, and resolution after its discontinuation. We explore the possibility of dupilumab-induced suppression of Th2 mediated inflammation and upregulation of Th1 and IFNγ mediated inflammation as a possible mechanism.
9
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky et al. · New England Journal of Medicine · 2016 · 2K citations · Full text
Medicine, Dermatology, Immunology +12
Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text
Medicine, Dermatology, Immunology +17
Development of Atopic Dermatitis-Like Skin Lesions in STAT6-Deficient NC/Nga Mice
Ryouji Yagi, Haruko Nagai, Yutaka Iigo et al. · The Journal of Immunology · 2002 · 130 citations · Full text
Medicine, Dermatology, Immunology +17